Skip to main content
CLDX logo
CLDX
(NASDAQ)
Celldex Therapeutics, Inc.
$33.41-- (--)
Loading... - Market loading

Celldex Therapeutics, Inc. (CLDX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Celldex Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(12 total ratings in last 90 days)
High Confidence:1 Buy/Sell

Average Price Target

$47.40
41.87% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CLDX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Joseph Pantginis
HC Wainwright
BuyReiterates
$42.00
Andy Chen
Wolfe Research
BuyMaintains
$51.00 $44.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$30.00
Judah Frommer
Morgan Stanley
BuyMaintains
$44.00
David Dai
UBS
BuyMaintains
$38.00 $45.00
Derek Archila
Wells Fargo
BuyReiterates
$38.00 $54.00
Edward Nash
Canaccord Genuity
BuyMaintains
$62.00
Sam Slutsky
LifeSci Capital
BuyReiterates
$67.00
Richard Law CFA
Goldman Sachs
HoldMaintains
$34.00 $38.00
Etzer Darout
Barclays
BuyInitiates Coverage
$45.00 $48.00
Yaron Werber
TD Cowen
BuyMaintains
-
Etzer Darout
Barclays
BuyUpgrades
$24.00 $45.00

Frequently Asked Questions

What is the analyst consensus rating for CLDX?

The analyst consensus rating for CLDX is "Buy" based on 11 analyst recommendations.

What is the average price target for CLDX?

The average 12-month price target for CLDX is $47.40, representing an upside of 41.9% from the current price of $33.41.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.